Cargando…
Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis
Background: Intrahepatic cholestasis of pregnancy (ICP) seriously threatens the health of pregnant women and newborns. A various number of Chinese prescriptions and patent medicines combined with ursodeoxycholic acid (UDCA) are used for treating ICP in China. However, there are still many doubts in...
Autores principales: | Jiang, Yinxiao, Li, Haotian, Song, Dan, Ye, Penghui, Xu, Nuo, Chen, Yuan, Zhang, Wenwen, Hu, Qichao, Ma, Xiao, Wen, Jianxia, Li, Yeyu, Zhao, Yanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670235/ https://www.ncbi.nlm.nih.gov/pubmed/34916949 http://dx.doi.org/10.3389/fphar.2021.774884 |
Ejemplares similares
-
Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis
por: Xie, Shuying, et al.
Publicado: (2023) -
Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects
por: Shan, Dan, et al.
Publicado: (2023) -
Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review
por: Li, Yubing, et al.
Publicado: (2023) -
Intrahepatic cholestasis of pregnancy
por: Pusl, Thomas, et al.
Publicado: (2007) -
Intrahepatic Cholestasis of Pregnancy
por: Jurk, Stanisław M., et al.
Publicado: (2021)